nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—pancreatic cancer	0.439	1	CbGaD
Trimethoprim—TYMS—Gemcitabine—pancreatic cancer	0.145	0.331	CbGbCtD
Trimethoprim—TYMS—Fluorouracil—pancreatic cancer	0.124	0.283	CbGbCtD
Trimethoprim—CYP2C8—Tamoxifen—pancreatic cancer	0.0191	0.0435	CbGbCtD
Trimethoprim—CYP2C8—Erlotinib—pancreatic cancer	0.0162	0.037	CbGbCtD
Trimethoprim—CYP2C8—Fluorouracil—pancreatic cancer	0.0141	0.0321	CbGbCtD
Trimethoprim—CYP2C9—Tamoxifen—pancreatic cancer	0.0133	0.0304	CbGbCtD
Trimethoprim—ABCB1—Tamoxifen—pancreatic cancer	0.0129	0.0295	CbGbCtD
Trimethoprim—ABCB1—Gemcitabine—pancreatic cancer	0.0111	0.0254	CbGbCtD
Trimethoprim—ABCB1—Erlotinib—pancreatic cancer	0.011	0.0251	CbGbCtD
Trimethoprim—ABCB1—Irinotecan—pancreatic cancer	0.00992	0.0226	CbGbCtD
Trimethoprim—CYP2C9—Fluorouracil—pancreatic cancer	0.00981	0.0224	CbGbCtD
Trimethoprim—CYP3A4—Tamoxifen—pancreatic cancer	0.00774	0.0177	CbGbCtD
Trimethoprim—ABCB1—Docetaxel—pancreatic cancer	0.00727	0.0166	CbGbCtD
Trimethoprim—ABCB1—Sunitinib—pancreatic cancer	0.00724	0.0165	CbGbCtD
Trimethoprim—CYP3A4—Erlotinib—pancreatic cancer	0.00658	0.015	CbGbCtD
Trimethoprim—CYP3A4—Irinotecan—pancreatic cancer	0.00594	0.0136	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—pancreatic cancer	0.00542	0.0124	CbGbCtD
Trimethoprim—CYP3A4—Docetaxel—pancreatic cancer	0.00436	0.00994	CbGbCtD
Trimethoprim—CYP3A4—Sunitinib—pancreatic cancer	0.00434	0.00989	CbGbCtD
Trimethoprim—CYP3A4—Doxorubicin—pancreatic cancer	0.00325	0.00741	CbGbCtD
Trimethoprim—TYMS—Paclitaxel—Docetaxel—pancreatic cancer	0.00105	0.451	CbGdCrCtD
Trimethoprim—TYMS—Gefitinib—Erlotinib—pancreatic cancer	0.00101	0.432	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Gemcitabine—pancreatic cancer	0.000271	0.117	CbGdCrCtD
Trimethoprim—Eye disorder—Docetaxel—pancreatic cancer	0.000137	0.00149	CcSEcCtD
Trimethoprim—Insomnia—Irinotecan—pancreatic cancer	0.000136	0.00148	CcSEcCtD
Trimethoprim—Vomiting—Tamoxifen—pancreatic cancer	0.000136	0.00148	CcSEcCtD
Trimethoprim—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000136	0.00148	CcSEcCtD
Trimethoprim—Lethargy—Doxorubicin—pancreatic cancer	0.000135	0.00147	CcSEcCtD
Trimethoprim—Hypersensitivity—Sunitinib—pancreatic cancer	0.000135	0.00147	CcSEcCtD
Trimethoprim—Rash—Tamoxifen—pancreatic cancer	0.000135	0.00147	CcSEcCtD
Trimethoprim—Dermatitis—Tamoxifen—pancreatic cancer	0.000135	0.00147	CcSEcCtD
Trimethoprim—Ataxia—Epirubicin—pancreatic cancer	0.000135	0.00146	CcSEcCtD
Trimethoprim—Vomiting—Erlotinib—pancreatic cancer	0.000134	0.00146	CcSEcCtD
Trimethoprim—Dyspnoea—Irinotecan—pancreatic cancer	0.000134	0.00146	CcSEcCtD
Trimethoprim—Headache—Tamoxifen—pancreatic cancer	0.000134	0.00146	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000134	0.00146	CcSEcCtD
Trimethoprim—Rash—Erlotinib—pancreatic cancer	0.000133	0.00145	CcSEcCtD
Trimethoprim—Dermatitis—Erlotinib—pancreatic cancer	0.000133	0.00145	CcSEcCtD
Trimethoprim—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000133	0.00145	CcSEcCtD
Trimethoprim—Insomnia—Gemcitabine—pancreatic cancer	0.000133	0.00145	CcSEcCtD
Trimethoprim—Dyspepsia—Irinotecan—pancreatic cancer	0.000133	0.00144	CcSEcCtD
Trimethoprim—Immune system disorder—Docetaxel—pancreatic cancer	0.000133	0.00144	CcSEcCtD
Trimethoprim—Headache—Erlotinib—pancreatic cancer	0.000132	0.00144	CcSEcCtD
Trimethoprim—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000132	0.00144	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000132	0.00143	CcSEcCtD
Trimethoprim—Decreased appetite—Irinotecan—pancreatic cancer	0.000131	0.00143	CcSEcCtD
Trimethoprim—Dyspnoea—Gemcitabine—pancreatic cancer	0.000131	0.00143	CcSEcCtD
Trimethoprim—Insomnia—Fluorouracil—pancreatic cancer	0.000131	0.00142	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00013	0.00142	CcSEcCtD
Trimethoprim—Pruritus—Sunitinib—pancreatic cancer	0.00013	0.00141	CcSEcCtD
Trimethoprim—Constipation—Irinotecan—pancreatic cancer	0.000129	0.0014	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000129	0.0014	CcSEcCtD
Trimethoprim—Dyspnoea—Fluorouracil—pancreatic cancer	0.000129	0.0014	CcSEcCtD
Trimethoprim—Mental disorder—Docetaxel—pancreatic cancer	0.000129	0.0014	CcSEcCtD
Trimethoprim—Erythema—Docetaxel—pancreatic cancer	0.000128	0.00139	CcSEcCtD
Trimethoprim—Malnutrition—Docetaxel—pancreatic cancer	0.000128	0.00139	CcSEcCtD
Trimethoprim—Decreased appetite—Gemcitabine—pancreatic cancer	0.000128	0.00139	CcSEcCtD
Trimethoprim—Dyspepsia—Fluorouracil—pancreatic cancer	0.000127	0.00138	CcSEcCtD
Trimethoprim—Nausea—Tamoxifen—pancreatic cancer	0.000127	0.00138	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000127	0.00138	CcSEcCtD
Trimethoprim—Constipation—Gemcitabine—pancreatic cancer	0.000126	0.00137	CcSEcCtD
Trimethoprim—Nausea—Erlotinib—pancreatic cancer	0.000126	0.00137	CcSEcCtD
Trimethoprim—Decreased appetite—Fluorouracil—pancreatic cancer	0.000126	0.00137	CcSEcCtD
Trimethoprim—Diarrhoea—Sunitinib—pancreatic cancer	0.000125	0.00136	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000125	0.00136	CcSEcCtD
Trimethoprim—Ataxia—Doxorubicin—pancreatic cancer	0.000124	0.00135	CcSEcCtD
Trimethoprim—Feeling abnormal—Irinotecan—pancreatic cancer	0.000124	0.00135	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000123	0.00134	CcSEcCtD
Trimethoprim—Eosinophilia—Epirubicin—pancreatic cancer	0.000122	0.00133	CcSEcCtD
Trimethoprim—Pancreatitis—Epirubicin—pancreatic cancer	0.000121	0.00132	CcSEcCtD
Trimethoprim—Dizziness—Sunitinib—pancreatic cancer	0.000121	0.00132	CcSEcCtD
Trimethoprim—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000121	0.00132	CcSEcCtD
Trimethoprim—Abdominal pain—Irinotecan—pancreatic cancer	0.000119	0.0013	CcSEcCtD
Trimethoprim—Body temperature increased—Irinotecan—pancreatic cancer	0.000119	0.0013	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000119	0.0013	CcSEcCtD
Trimethoprim—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000119	0.0013	CcSEcCtD
Trimethoprim—Pancytopenia—Epirubicin—pancreatic cancer	0.000117	0.00128	CcSEcCtD
Trimethoprim—Vomiting—Sunitinib—pancreatic cancer	0.000116	0.00127	CcSEcCtD
Trimethoprim—Body temperature increased—Gemcitabine—pancreatic cancer	0.000116	0.00126	CcSEcCtD
Trimethoprim—Neutropenia—Epirubicin—pancreatic cancer	0.000116	0.00126	CcSEcCtD
Trimethoprim—Rash—Sunitinib—pancreatic cancer	0.000115	0.00126	CcSEcCtD
Trimethoprim—Dermatitis—Sunitinib—pancreatic cancer	0.000115	0.00126	CcSEcCtD
Trimethoprim—Urticaria—Fluorouracil—pancreatic cancer	0.000115	0.00125	CcSEcCtD
Trimethoprim—Headache—Sunitinib—pancreatic cancer	0.000115	0.00125	CcSEcCtD
Trimethoprim—Syncope—Docetaxel—pancreatic cancer	0.000115	0.00125	CcSEcCtD
Trimethoprim—Leukopenia—Docetaxel—pancreatic cancer	0.000114	0.00124	CcSEcCtD
Trimethoprim—Body temperature increased—Fluorouracil—pancreatic cancer	0.000114	0.00124	CcSEcCtD
Trimethoprim—Eosinophilia—Doxorubicin—pancreatic cancer	0.000113	0.00123	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000113	0.00123	CcSEcCtD
Trimethoprim—Loss of consciousness—Docetaxel—pancreatic cancer	0.000112	0.00122	CcSEcCtD
Trimethoprim—Pancreatitis—Doxorubicin—pancreatic cancer	0.000112	0.00122	CcSEcCtD
Trimethoprim—Cough—Docetaxel—pancreatic cancer	0.000111	0.00121	CcSEcCtD
Trimethoprim—Hypersensitivity—Irinotecan—pancreatic cancer	0.000111	0.00121	CcSEcCtD
Trimethoprim—Pneumonia—Epirubicin—pancreatic cancer	0.000111	0.00121	CcSEcCtD
Trimethoprim—Convulsion—Docetaxel—pancreatic cancer	0.000111	0.0012	CcSEcCtD
Trimethoprim—Infestation NOS—Epirubicin—pancreatic cancer	0.00011	0.0012	CcSEcCtD
Trimethoprim—Infestation—Epirubicin—pancreatic cancer	0.00011	0.0012	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000109	0.00119	CcSEcCtD
Trimethoprim—Arthralgia—Docetaxel—pancreatic cancer	0.000109	0.00118	CcSEcCtD
Trimethoprim—Myalgia—Docetaxel—pancreatic cancer	0.000109	0.00118	CcSEcCtD
Trimethoprim—Nausea—Sunitinib—pancreatic cancer	0.000109	0.00118	CcSEcCtD
Trimethoprim—Pancytopenia—Doxorubicin—pancreatic cancer	0.000109	0.00118	CcSEcCtD
Trimethoprim—Renal failure—Epirubicin—pancreatic cancer	0.000108	0.00118	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000108	0.00118	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000108	0.00118	CcSEcCtD
Trimethoprim—Stomatitis—Epirubicin—pancreatic cancer	0.000107	0.00117	CcSEcCtD
Trimethoprim—Neutropenia—Doxorubicin—pancreatic cancer	0.000107	0.00116	CcSEcCtD
Trimethoprim—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000106	0.00116	CcSEcCtD
Trimethoprim—Haematuria—Epirubicin—pancreatic cancer	0.000105	0.00114	CcSEcCtD
Trimethoprim—Confusional state—Docetaxel—pancreatic cancer	0.000105	0.00114	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000104	0.00114	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000104	0.00113	CcSEcCtD
Trimethoprim—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000104	0.00113	CcSEcCtD
Trimethoprim—Epistaxis—Epirubicin—pancreatic cancer	0.000104	0.00113	CcSEcCtD
Trimethoprim—Pruritus—Gemcitabine—pancreatic cancer	0.000104	0.00113	CcSEcCtD
Trimethoprim—Diarrhoea—Irinotecan—pancreatic cancer	0.000103	0.00112	CcSEcCtD
Trimethoprim—Agranulocytosis—Epirubicin—pancreatic cancer	0.000103	0.00112	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—pancreatic cancer	0.000103	0.00112	CcSEcCtD
Trimethoprim—Shock—Docetaxel—pancreatic cancer	0.000103	0.00112	CcSEcCtD
Trimethoprim—Nervous system disorder—Docetaxel—pancreatic cancer	0.000102	0.00111	CcSEcCtD
Trimethoprim—Pruritus—Fluorouracil—pancreatic cancer	0.000102	0.00111	CcSEcCtD
Trimethoprim—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000102	0.00111	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—pancreatic cancer	0.000102	0.00111	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—pancreatic cancer	0.000102	0.00111	CcSEcCtD
Trimethoprim—Skin disorder—Docetaxel—pancreatic cancer	0.000101	0.0011	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000101	0.0011	CcSEcCtD
Trimethoprim—Diarrhoea—Gemcitabine—pancreatic cancer	0.000101	0.00109	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—pancreatic cancer	0.0001	0.00109	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.0001	0.00109	CcSEcCtD
Trimethoprim—Dizziness—Irinotecan—pancreatic cancer	9.97e-05	0.00109	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—pancreatic cancer	9.94e-05	0.00108	CcSEcCtD
Trimethoprim—Anorexia—Docetaxel—pancreatic cancer	9.94e-05	0.00108	CcSEcCtD
Trimethoprim—Diarrhoea—Fluorouracil—pancreatic cancer	9.88e-05	0.00108	CcSEcCtD
Trimethoprim—Urinary tract disorder—Epirubicin—pancreatic cancer	9.77e-05	0.00106	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—pancreatic cancer	9.73e-05	0.00106	CcSEcCtD
Trimethoprim—Connective tissue disorder—Epirubicin—pancreatic cancer	9.73e-05	0.00106	CcSEcCtD
Trimethoprim—Urethral disorder—Epirubicin—pancreatic cancer	9.7e-05	0.00106	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—pancreatic cancer	9.65e-05	0.00105	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—pancreatic cancer	9.62e-05	0.00105	CcSEcCtD
Trimethoprim—Vomiting—Irinotecan—pancreatic cancer	9.59e-05	0.00104	CcSEcCtD
Trimethoprim—Dizziness—Fluorouracil—pancreatic cancer	9.55e-05	0.00104	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—pancreatic cancer	9.52e-05	0.00104	CcSEcCtD
Trimethoprim—Rash—Irinotecan—pancreatic cancer	9.51e-05	0.00104	CcSEcCtD
Trimethoprim—Dermatitis—Irinotecan—pancreatic cancer	9.5e-05	0.00103	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.5e-05	0.00103	CcSEcCtD
Trimethoprim—Headache—Irinotecan—pancreatic cancer	9.45e-05	0.00103	CcSEcCtD
Trimethoprim—Insomnia—Docetaxel—pancreatic cancer	9.43e-05	0.00103	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—pancreatic cancer	9.36e-05	0.00102	CcSEcCtD
Trimethoprim—Vomiting—Gemcitabine—pancreatic cancer	9.34e-05	0.00102	CcSEcCtD
Trimethoprim—Dyspnoea—Docetaxel—pancreatic cancer	9.29e-05	0.00101	CcSEcCtD
Trimethoprim—Rash—Gemcitabine—pancreatic cancer	9.26e-05	0.00101	CcSEcCtD
Trimethoprim—Dermatitis—Gemcitabine—pancreatic cancer	9.25e-05	0.00101	CcSEcCtD
Trimethoprim—Eye disorder—Epirubicin—pancreatic cancer	9.25e-05	0.00101	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—pancreatic cancer	9.23e-05	0.001	CcSEcCtD
Trimethoprim—Headache—Gemcitabine—pancreatic cancer	9.2e-05	0.001	CcSEcCtD
Trimethoprim—Vomiting—Fluorouracil—pancreatic cancer	9.18e-05	0.001	CcSEcCtD
Trimethoprim—Dyspepsia—Docetaxel—pancreatic cancer	9.18e-05	0.000999	CcSEcCtD
Trimethoprim—Rash—Fluorouracil—pancreatic cancer	9.11e-05	0.000991	CcSEcCtD
Trimethoprim—Dermatitis—Fluorouracil—pancreatic cancer	9.1e-05	0.00099	CcSEcCtD
Trimethoprim—Decreased appetite—Docetaxel—pancreatic cancer	9.06e-05	0.000986	CcSEcCtD
Trimethoprim—Headache—Fluorouracil—pancreatic cancer	9.05e-05	0.000985	CcSEcCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—pancreatic cancer	9.04e-05	0.000984	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9e-05	0.00098	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—pancreatic cancer	9e-05	0.00098	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—pancreatic cancer	8.98e-05	0.000977	CcSEcCtD
Trimethoprim—Nausea—Irinotecan—pancreatic cancer	8.96e-05	0.000975	CcSEcCtD
Trimethoprim—Immune system disorder—Epirubicin—pancreatic cancer	8.94e-05	0.000973	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—pancreatic cancer	8.92e-05	0.000971	CcSEcCtD
Trimethoprim—Constipation—Docetaxel—pancreatic cancer	8.91e-05	0.00097	CcSEcCtD
Trimethoprim—Nausea—Gemcitabine—pancreatic cancer	8.73e-05	0.00095	CcSEcCtD
Trimethoprim—Mental disorder—Epirubicin—pancreatic cancer	8.67e-05	0.000944	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—pancreatic cancer	8.66e-05	0.000942	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—pancreatic cancer	8.62e-05	0.000938	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—pancreatic cancer	8.62e-05	0.000938	CcSEcCtD
Trimethoprim—Feeling abnormal—Docetaxel—pancreatic cancer	8.59e-05	0.000935	CcSEcCtD
Trimethoprim—Nausea—Fluorouracil—pancreatic cancer	8.58e-05	0.000934	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—pancreatic cancer	8.56e-05	0.000932	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—pancreatic cancer	8.54e-05	0.000929	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.52e-05	0.000928	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—pancreatic cancer	8.27e-05	0.0009	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—pancreatic cancer	8.25e-05	0.000898	CcSEcCtD
Trimethoprim—Abdominal pain—Docetaxel—pancreatic cancer	8.24e-05	0.000897	CcSEcCtD
Trimethoprim—Body temperature increased—Docetaxel—pancreatic cancer	8.24e-05	0.000897	CcSEcCtD
Trimethoprim—Mental disorder—Doxorubicin—pancreatic cancer	8.02e-05	0.000873	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—pancreatic cancer	7.97e-05	0.000868	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—pancreatic cancer	7.97e-05	0.000868	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—pancreatic cancer	7.92e-05	0.000862	CcSEcCtD
Trimethoprim—Vertigo—Epirubicin—pancreatic cancer	7.74e-05	0.000843	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—pancreatic cancer	7.73e-05	0.000841	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—pancreatic cancer	7.71e-05	0.000839	CcSEcCtD
Trimethoprim—Hypersensitivity—Docetaxel—pancreatic cancer	7.68e-05	0.000836	CcSEcCtD
Trimethoprim—Loss of consciousness—Epirubicin—pancreatic cancer	7.57e-05	0.000824	CcSEcCtD
Trimethoprim—Cough—Epirubicin—pancreatic cancer	7.52e-05	0.000818	CcSEcCtD
Trimethoprim—Convulsion—Epirubicin—pancreatic cancer	7.46e-05	0.000813	CcSEcCtD
Trimethoprim—Pruritus—Docetaxel—pancreatic cancer	7.38e-05	0.000803	CcSEcCtD
Trimethoprim—Arthralgia—Epirubicin—pancreatic cancer	7.33e-05	0.000798	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—pancreatic cancer	7.33e-05	0.000798	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—pancreatic cancer	7.33e-05	0.000797	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—pancreatic cancer	7.31e-05	0.000796	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.28e-05	0.000793	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—pancreatic cancer	7.16e-05	0.00078	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—pancreatic cancer	7.15e-05	0.000778	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—pancreatic cancer	7.14e-05	0.000777	CcSEcCtD
Trimethoprim—Diarrhoea—Docetaxel—pancreatic cancer	7.13e-05	0.000776	CcSEcCtD
Trimethoprim—Confusional state—Epirubicin—pancreatic cancer	7.09e-05	0.000772	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—pancreatic cancer	7.03e-05	0.000765	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—pancreatic cancer	7.01e-05	0.000763	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—pancreatic cancer	6.96e-05	0.000757	CcSEcCtD
Trimethoprim—Shock—Epirubicin—pancreatic cancer	6.92e-05	0.000753	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—pancreatic cancer	6.91e-05	0.000752	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—pancreatic cancer	6.9e-05	0.000751	CcSEcCtD
Trimethoprim—Dizziness—Docetaxel—pancreatic cancer	6.89e-05	0.00075	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—pancreatic cancer	6.88e-05	0.000749	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—pancreatic cancer	6.83e-05	0.000743	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—pancreatic cancer	6.79e-05	0.000739	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—pancreatic cancer	6.79e-05	0.000739	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—pancreatic cancer	6.76e-05	0.000736	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.74e-05	0.000734	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—pancreatic cancer	6.7e-05	0.00073	CcSEcCtD
Trimethoprim—Vomiting—Docetaxel—pancreatic cancer	6.63e-05	0.000721	CcSEcCtD
Trimethoprim—Rash—Docetaxel—pancreatic cancer	6.57e-05	0.000715	CcSEcCtD
Trimethoprim—Dermatitis—Docetaxel—pancreatic cancer	6.57e-05	0.000715	CcSEcCtD
Trimethoprim—Confusional state—Doxorubicin—pancreatic cancer	6.56e-05	0.000714	CcSEcCtD
Trimethoprim—Headache—Docetaxel—pancreatic cancer	6.53e-05	0.000711	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.51e-05	0.000708	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.41e-05	0.000697	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—pancreatic cancer	6.4e-05	0.000697	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—pancreatic cancer	6.38e-05	0.000695	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.37e-05	0.000693	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—pancreatic cancer	6.36e-05	0.000692	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—pancreatic cancer	6.32e-05	0.000688	CcSEcCtD
Trimethoprim—Dyspnoea—Epirubicin—pancreatic cancer	6.27e-05	0.000682	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—pancreatic cancer	6.2e-05	0.000675	CcSEcCtD
Trimethoprim—Nausea—Docetaxel—pancreatic cancer	6.19e-05	0.000674	CcSEcCtD
Trimethoprim—Dyspepsia—Epirubicin—pancreatic cancer	6.19e-05	0.000674	CcSEcCtD
Trimethoprim—Decreased appetite—Epirubicin—pancreatic cancer	6.11e-05	0.000665	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.07e-05	0.000661	CcSEcCtD
Trimethoprim—Constipation—Epirubicin—pancreatic cancer	6.01e-05	0.000655	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.93e-05	0.000645	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—pancreatic cancer	5.88e-05	0.000641	CcSEcCtD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	5.87e-05	0.00207	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PRSS1—pancreatic cancer	5.81e-05	0.00204	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	5.8e-05	0.00204	CbGpPWpGaD
Trimethoprim—Dyspnoea—Doxorubicin—pancreatic cancer	5.8e-05	0.000631	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—pancreatic cancer	5.79e-05	0.000631	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.75e-05	0.000626	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—pancreatic cancer	5.73e-05	0.000623	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—MYC—pancreatic cancer	5.7e-05	0.00201	CbGpPWpGaD
Trimethoprim—Decreased appetite—Doxorubicin—pancreatic cancer	5.66e-05	0.000616	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.62e-05	0.000611	CcSEcCtD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	5.61e-05	0.00198	CbGpPWpGaD
Trimethoprim—Urticaria—Epirubicin—pancreatic cancer	5.59e-05	0.000608	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—pancreatic cancer	5.56e-05	0.000606	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—pancreatic cancer	5.56e-05	0.000605	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—pancreatic cancer	5.56e-05	0.000605	CcSEcCtD
Trimethoprim—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.38e-05	0.00189	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Doxorubicin—pancreatic cancer	5.36e-05	0.000584	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.32e-05	0.000579	CcSEcCtD
Trimethoprim—DHFR—Disease—DTX4—pancreatic cancer	5.25e-05	0.00185	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	5.2e-05	0.00183	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Epirubicin—pancreatic cancer	5.18e-05	0.000564	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—TYMS—pancreatic cancer	5.18e-05	0.00182	CbGpPWpGaD
Trimethoprim—Urticaria—Doxorubicin—pancreatic cancer	5.17e-05	0.000563	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—pancreatic cancer	5.14e-05	0.00056	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—pancreatic cancer	5.14e-05	0.00056	CcSEcCtD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	5.13e-05	0.00181	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PPP2R5B—pancreatic cancer	5.11e-05	0.0018	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PRSS1—pancreatic cancer	5.07e-05	0.00178	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	5.04e-05	0.00177	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ARG2—pancreatic cancer	5.03e-05	0.00177	CbGpPWpGaD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5e-05	0.00176	CbGpPWpGaD
Trimethoprim—Pruritus—Epirubicin—pancreatic cancer	4.97e-05	0.000542	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—MYC—pancreatic cancer	4.97e-05	0.00175	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HEY2—pancreatic cancer	4.92e-05	0.00173	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—BRCA2—pancreatic cancer	4.87e-05	0.00171	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4.83e-05	0.0017	CbGpPWpGaD
Trimethoprim—Diarrhoea—Epirubicin—pancreatic cancer	4.81e-05	0.000524	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—pancreatic cancer	4.79e-05	0.000522	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.7e-05	0.00165	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.65e-05	0.00164	CbGpPWpGaD
Trimethoprim—Dizziness—Epirubicin—pancreatic cancer	4.65e-05	0.000506	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—TYMS—pancreatic cancer	4.63e-05	0.00163	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	4.61e-05	0.00162	CbGpPWpGaD
Trimethoprim—Pruritus—Doxorubicin—pancreatic cancer	4.6e-05	0.000501	CcSEcCtD
Trimethoprim—DHFR—Disease—HEY1—pancreatic cancer	4.56e-05	0.0016	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	4.55e-05	0.0016	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.53e-05	0.0016	CbGpPWpGaD
Trimethoprim—Vomiting—Epirubicin—pancreatic cancer	4.47e-05	0.000487	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—pancreatic cancer	4.45e-05	0.000485	CcSEcCtD
Trimethoprim—Rash—Epirubicin—pancreatic cancer	4.43e-05	0.000483	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—pancreatic cancer	4.43e-05	0.000482	CcSEcCtD
Trimethoprim—Headache—Epirubicin—pancreatic cancer	4.4e-05	0.000479	CcSEcCtD
Trimethoprim—DHFR—Metabolism—TYMP—pancreatic cancer	4.4e-05	0.00155	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ARG2—pancreatic cancer	4.39e-05	0.00155	CbGpPWpGaD
Trimethoprim—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	4.38e-05	0.00154	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—PTEN—pancreatic cancer	4.35e-05	0.00153	CbGpPWpGaD
Trimethoprim—Dizziness—Doxorubicin—pancreatic cancer	4.3e-05	0.000468	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—BRCA2—pancreatic cancer	4.25e-05	0.00149	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	4.2e-05	0.00148	CbGpPWpGaD
Trimethoprim—Nausea—Epirubicin—pancreatic cancer	4.18e-05	0.000455	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—pancreatic cancer	4.14e-05	0.00045	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—pancreatic cancer	4.1e-05	0.000447	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—pancreatic cancer	4.1e-05	0.000446	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	4.1e-05	0.00144	CbGpPWpGaD
Trimethoprim—Headache—Doxorubicin—pancreatic cancer	4.08e-05	0.000444	CcSEcCtD
Trimethoprim—DHFR—Disease—JAG2—pancreatic cancer	4.04e-05	0.00142	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TERT—pancreatic cancer	4.03e-05	0.00142	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MEN1—pancreatic cancer	3.98e-05	0.0014	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	3.98e-05	0.0014	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SLC2A2—pancreatic cancer	3.95e-05	0.00139	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	3.91e-05	0.00138	CbGpPWpGaD
Trimethoprim—Nausea—Doxorubicin—pancreatic cancer	3.86e-05	0.000421	CcSEcCtD
Trimethoprim—TYMS—Metabolism—TYMP—pancreatic cancer	3.84e-05	0.00135	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SHH—pancreatic cancer	3.8e-05	0.00134	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.77e-05	0.00133	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.76e-05	0.00132	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IAPP—pancreatic cancer	3.75e-05	0.00132	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.69e-05	0.0013	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HSPA1B—pancreatic cancer	3.6e-05	0.00127	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GLP1R—pancreatic cancer	3.55e-05	0.00125	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TERT—pancreatic cancer	3.52e-05	0.00124	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.51e-05	0.00124	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—RB1—pancreatic cancer	3.51e-05	0.00124	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—DPYD—pancreatic cancer	3.49e-05	0.00123	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.48e-05	0.00123	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	3.45e-05	0.00122	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	3.35e-05	0.00118	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—SLC2A2—pancreatic cancer	3.31e-05	0.00117	CbGpPWpGaD
Trimethoprim—DHFR—Disease—JAG1—pancreatic cancer	3.22e-05	0.00113	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.2e-05	0.00113	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	3.15e-05	0.00111	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—RB1—pancreatic cancer	3.14e-05	0.0011	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GLP1R—pancreatic cancer	3.09e-05	0.00109	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.09e-05	0.00109	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	3.08e-05	0.00109	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—RB1—pancreatic cancer	3.06e-05	0.00108	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD44—pancreatic cancer	3.06e-05	0.00108	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—DPYD—pancreatic cancer	3.04e-05	0.00107	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HSPA1A—pancreatic cancer	3.04e-05	0.00107	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	3.03e-05	0.00107	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	3.02e-05	0.00106	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—pancreatic cancer	2.97e-05	0.00105	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	2.96e-05	0.00104	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	2.93e-05	0.00103	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SLC2A2—pancreatic cancer	2.89e-05	0.00102	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	2.88e-05	0.00101	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2A—pancreatic cancer	2.76e-05	0.000971	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—RB1—pancreatic cancer	2.74e-05	0.000964	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	2.69e-05	0.000948	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.61e-05	0.00092	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND1—pancreatic cancer	2.61e-05	0.000918	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CD44—pancreatic cancer	2.56e-05	0.000903	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	2.56e-05	0.000902	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GCG—pancreatic cancer	2.46e-05	0.000866	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SMAD4—pancreatic cancer	2.42e-05	0.000851	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2A—pancreatic cancer	2.41e-05	0.000847	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HES1—pancreatic cancer	2.36e-05	0.000831	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.35e-05	0.000827	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND1—pancreatic cancer	2.33e-05	0.00082	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—STK11—pancreatic cancer	2.31e-05	0.000814	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND1—pancreatic cancer	2.27e-05	0.000801	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CD44—pancreatic cancer	2.24e-05	0.000788	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TNF—pancreatic cancer	2.19e-05	0.000773	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.18e-05	0.000768	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GCG—pancreatic cancer	2.15e-05	0.000755	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—pancreatic cancer	2.09e-05	0.000736	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.09e-05	0.000735	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TERT—pancreatic cancer	2.07e-05	0.000728	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND1—pancreatic cancer	2.03e-05	0.000716	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—STK11—pancreatic cancer	2.02e-05	0.00071	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—TYMS—pancreatic cancer	1.99e-05	0.0007	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HIF1A—pancreatic cancer	1.98e-05	0.000696	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TSC2—pancreatic cancer	1.97e-05	0.000695	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APOE—pancreatic cancer	1.93e-05	0.00068	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.9e-05	0.00067	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.89e-05	0.000664	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—pancreatic cancer	1.87e-05	0.000658	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.82e-05	0.000642	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PRSS1—pancreatic cancer	1.79e-05	0.000632	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOTCH1—pancreatic cancer	1.78e-05	0.000627	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGF—pancreatic cancer	1.72e-05	0.000606	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—pancreatic cancer	1.63e-05	0.000574	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—APOE—pancreatic cancer	1.62e-05	0.000569	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.6e-05	0.000565	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.56e-05	0.00055	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ARG2—pancreatic cancer	1.56e-05	0.000548	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—pancreatic cancer	1.53e-05	0.00054	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CD—pancreatic cancer	1.53e-05	0.000539	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.49e-05	0.000524	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.46e-05	0.000514	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CG—pancreatic cancer	1.46e-05	0.000514	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.45e-05	0.00051	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.44e-05	0.000505	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—APOE—pancreatic cancer	1.41e-05	0.000497	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PPARG—pancreatic cancer	1.41e-05	0.000496	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.4e-05	0.000493	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TYMP—pancreatic cancer	1.36e-05	0.000479	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ARG2—pancreatic cancer	1.36e-05	0.000477	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—pancreatic cancer	1.34e-05	0.000472	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CB—pancreatic cancer	1.34e-05	0.00047	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—pancreatic cancer	1.32e-05	0.000466	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.3e-05	0.000457	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CD—pancreatic cancer	1.28e-05	0.000452	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CG—pancreatic cancer	1.27e-05	0.000448	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.27e-05	0.000446	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.26e-05	0.000445	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPARG—pancreatic cancer	1.23e-05	0.000433	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TYMP—pancreatic cancer	1.18e-05	0.000417	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CTNNB1—pancreatic cancer	1.18e-05	0.000417	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.16e-05	0.000409	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.16e-05	0.000408	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTEN—pancreatic cancer	1.15e-05	0.000406	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.14e-05	0.0004	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.12e-05	0.000395	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CD—pancreatic cancer	1.12e-05	0.000394	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CB—pancreatic cancer	1.12e-05	0.000394	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—pancreatic cancer	1.11e-05	0.00039	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.11e-05	0.00039	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.1e-05	0.000386	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.08e-05	0.000381	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.08e-05	0.00038	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.07e-05	0.000378	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SRC—pancreatic cancer	1.07e-05	0.000377	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—pancreatic cancer	1.03e-05	0.000363	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NRAS—pancreatic cancer	1.03e-05	0.000362	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.02e-05	0.00036	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.01e-05	0.000357	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	9.87e-06	0.000347	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.77e-06	0.000344	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CB—pancreatic cancer	9.76e-06	0.000344	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—pancreatic cancer	9.67e-06	0.00034	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—pancreatic cancer	9.66e-06	0.00034	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PRSS1—pancreatic cancer	9.63e-06	0.000339	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—pancreatic cancer	9.59e-06	0.000338	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—pancreatic cancer	9.57e-06	0.000337	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GLP1R—pancreatic cancer	9.55e-06	0.000336	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	9.55e-06	0.000336	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—DPYD—pancreatic cancer	9.39e-06	0.000331	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—pancreatic cancer	9.38e-06	0.00033	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.13e-06	0.000322	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GLP1R—pancreatic cancer	8.92e-06	0.000314	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC2A2—pancreatic cancer	8.91e-06	0.000314	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.9e-06	0.000313	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—pancreatic cancer	8.86e-06	0.000312	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—DPYD—pancreatic cancer	8.78e-06	0.000309	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—pancreatic cancer	8.43e-06	0.000297	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ARG2—pancreatic cancer	8.35e-06	0.000294	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	8.33e-06	0.000293	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.24e-06	0.00029	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—pancreatic cancer	8.14e-06	0.000287	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.06e-06	0.000284	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.95e-06	0.00028	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CD44—pancreatic cancer	7.92e-06	0.000279	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.76e-06	0.000273	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.69e-06	0.000271	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GCG—pancreatic cancer	7.6e-06	0.000268	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—pancreatic cancer	7.53e-06	0.000265	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TYMP—pancreatic cancer	7.3e-06	0.000257	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.25e-06	0.000255	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—STK11—pancreatic cancer	7.14e-06	0.000252	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CD44—pancreatic cancer	6.9e-06	0.000243	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—pancreatic cancer	6.82e-06	0.00024	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.71e-06	0.000236	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—pancreatic cancer	6.65e-06	0.000234	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GCG—pancreatic cancer	6.62e-06	0.000233	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CD44—pancreatic cancer	6.45e-06	0.000227	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.32e-06	0.000222	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.26e-06	0.00022	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—STK11—pancreatic cancer	6.22e-06	0.000219	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GCG—pancreatic cancer	6.18e-06	0.000218	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.14e-06	0.000216	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—pancreatic cancer	5.95e-06	0.000209	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.88e-06	0.000207	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—STK11—pancreatic cancer	5.81e-06	0.000205	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.79e-06	0.000204	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—pancreatic cancer	5.57e-06	0.000196	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.49e-06	0.000193	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.46e-06	0.000192	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TYMS—pancreatic cancer	5.35e-06	0.000188	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TYMS—pancreatic cancer	5e-06	0.000176	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOE—pancreatic cancer	5e-06	0.000176	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—pancreatic cancer	4.86e-06	0.000171	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.73e-06	0.000167	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	4.51e-06	0.000159	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOE—pancreatic cancer	4.35e-06	0.000153	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.35e-06	0.000153	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CD44—pancreatic cancer	4.25e-06	0.00015	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GCG—pancreatic cancer	4.08e-06	0.000144	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOE—pancreatic cancer	4.07e-06	0.000143	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.96e-06	0.00014	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.93e-06	0.000138	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.85e-06	0.000136	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—STK11—pancreatic cancer	3.83e-06	0.000135	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARG—pancreatic cancer	3.79e-06	0.000134	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.67e-06	0.000129	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.54e-06	0.000125	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.46e-06	0.000122	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.45e-06	0.000122	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.42e-06	0.000121	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.3e-06	0.000116	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.23e-06	0.000114	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.01e-06	0.000106	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.99e-06	0.000105	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.98e-06	0.000105	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.81e-06	9.9e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.79e-06	9.81e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOE—pancreatic cancer	2.68e-06	9.44e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—pancreatic cancer	2.6e-06	9.16e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.43e-06	8.56e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.42e-06	8.52e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.34e-06	8.23e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.13e-06	7.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.11e-06	7.42e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.85e-06	6.53e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.84e-06	6.47e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.84e-06	6.46e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.72e-06	6.06e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.71e-06	6.04e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.6e-06	5.64e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—pancreatic cancer	1.5e-06	5.28e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.4e-06	4.93e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.13e-06	3.98e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—pancreatic cancer	9.24e-07	3.25e-05	CbGpPWpGaD
